TISSUE REGENIX GROUP

TRX
Delayed Quote. Delayed  - 07/15 11:35:29 am
0.33GBX --.--%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Net sales1 0,010,101,575,2311,613,0
EBITDA1 -6,41-8,22-11,7-9,01-7,09-6,13
Operating profit (EBIT)1 -6,53-8,37-12,1-9,72-8,27-7,18
Operating Margin -108 883%-8 369%-766%-186%-71,1%-55,1%
Pre-Tax Profit (EBT)1 -6,30-8,20-11,9-10,8-8,88-7,66
Net income1 -5,59-7,58-10,7-9,22-8,19-6,97
Net margin -93 217%-7 581%-678%-176%-70,5%-53,5%
EPS2 -0,01-0,01-0,01-0,01-0,01-0,01
Dividend per Share ------
Last update 05/11/201505/23/201604/27/201806/04/201906/05/202006/05/2020
1 GBP in Million
2 GBP
Finances - Leverage
Fiscal Period: December 2014 2015 2016 2017 2018 2019
Net Debt1 ------
Net Cash position1 18,510,38,1716,47,820,09
Leverage (Debt / EBITDA) 2,88x1,25x0,70x1,82x1,10x0,02x
Free Cash Flow1 -4,22-5,88-6,28-6,09-5,14-6,57
ROE (Net Profit / Equities) -25,7%-49,6%-57,9%-36,9%-22,9%-24,9%
Shareholders' equity1 21,715,318,425,035,728,0
ROA (Net Profit / Asset) -18,1%-31,9%-35,7%-20,5%-12,4%-13,2%
Assets1 31,023,729,945,166,153,0
Book Value Per Share2 0,030,020,020,030,030,02
Cash Flow per Share2 0,030,020,010,010,010,00
Capex1 0,360,110,530,130,290,44
Capex / Sales 5 967%114%33,7%2,48%2,50%3,36%
Last update 05/11/201505/23/201604/27/201806/04/201906/05/202006/05/2020
1 GBP in Million
2 GBP
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 23 M GBP -
Valuation 2020e 2021e
P/E ratio (Price / EPS) - -
Capitalization / Revenue - -
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) - -
Operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) - -
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   - -
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend